Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.70 EUR
62.37 M EUR
1.14 B EUR
16.96 M
About DERMAPHARM HLDG SE
Sector
CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Website
Founded
2017
ISIN
DE000A2GS5D8
FIGI
BBG00JRJQWS8
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DMP is 38.75 EUR — it has increased by 1.71% in the past 24 hours. Watch DERMAPHARM HLDG INH O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DERMAPHARM HLDG INH O.N. stocks are traded under the ticker DMP.
DMP stock has risen by 2.51% compared to the previous week, the month change is a 7.04% rise, over the last year DERMAPHARM HLDG INH O.N. has showed a −8.52% decrease.
We've gathered analysts' opinions on DERMAPHARM HLDG INH O.N. future price: according to them, DMP price has a max estimate of 50.00 EUR and a min estimate of 41.50 EUR. Watch DMP chart and read a more detailed DERMAPHARM HLDG INH O.N. stock forecast: see what analysts think of DERMAPHARM HLDG INH O.N. and suggest that you do with its stocks.
DMP stock is 1.70% volatile and has beta coefficient of 0.48. Track DERMAPHARM HLDG INH O.N. stock price on the chart and check out the list of the most volatile stocks — is DERMAPHARM HLDG INH O.N. there?
Today DERMAPHARM HLDG INH O.N. has the market capitalization of 2.07 B, it has decreased by −0.53% over the last week.
Yes, you can track DERMAPHARM HLDG INH O.N. financials in yearly and quarterly reports right on TradingView.
DERMAPHARM HLDG INH O.N. is going to release the next earnings report on Apr 9, 2025. Keep track of upcoming events with our Earnings Calendar.
DERMAPHARM HLDG INH O.N. revenue for the last quarter amounts to 311.60 M EUR, despite the estimated figure of 296.30 M EUR. In the next quarter, revenue is expected to reach 295.20 M EUR.
DMP net income for the last quarter is 32.39 M EUR, while the quarter before that showed 17.27 M EUR of net income which accounts for 87.59% change. Track more DERMAPHARM HLDG INH O.N. financial stats to get the full picture.
Yes, DMP dividends are paid annually. The last dividend per share was 0.88 EUR. As of today, Dividend Yield (TTM)% is 2.29%. Tracking DERMAPHARM HLDG INH O.N. dividends might help you take more informed decisions.
DERMAPHARM HLDG INH O.N. dividend yield was 2.08% in 2023, and payout ratio reached 75.97%. The year before the numbers were 2.80% and 42.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HLDG INH O.N. EBITDA is 305.56 M EUR, and current EBITDA margin is 26.86%. See more stats in DERMAPHARM HLDG INH O.N. financial statements.
Like other stocks, DMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HLDG INH O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DERMAPHARM HLDG INH O.N. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DERMAPHARM HLDG INH O.N. stock shows the buy signal. See more of DERMAPHARM HLDG INH O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.